Creative Planning Spectrum Pharmaceuticals Inc Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.32 - $0.52 $31 - $51	-99 Reduced 0.6%	16,432 $6,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $1 - $2	-1 Reduced 0.01%	16,531 $21,000
Q1 2021 Apr 30, 2021	SELL	$2.9 - $4.09 $5,797 - $8,175	-1,999 Reduced 10.79%	16,532 $54,000
Q3 2020 Nov 05, 2020	SELL	$2.99 - $4.9 $44,850 - $73,500	-15,000 Reduced 44.73%	18,531 $76,000
Q2 2020 Jul 23, 2020	BUY	$2.11 - $3.38 $28,485 - $45,630	13,500 Added 67.4%	33,531 $113,000
Q1 2020 May 05, 2020	SELL	$1.83 - $3.45 $1,830 - $3,450	-1,000 Reduced 4.75%	20,031 $47,000
Q4 2019 Jan 30, 2020	BUY	$3.5 - $10.35 $73,608 - $217,670	21,031 New	21,031 $77,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.